Clinical Updates in Drug-Eluting Technologies for the Treatment of Peripheral Vascular Disease
Paclitaxel or Limus: What Is the Future in Drug Eluting Therapies?
By
ARCH Advanced Revascularization Symposium
FEATURING
Craig Walker
By
ARCH Advanced Revascularization Symposium
FEATURING
Craig Walker
Login to view comments.
Click here to Login
Clinical Updates in Drug-Eluting Technologies for the Treatment of Peripheral Vascular Disease